Find comprehensive information on keratoacanthoma, including clinical documentation, ICD-10 codes (L87.0), SNOMED CT codes, histopathology, differential diagnosis (squamous cell carcinoma), treatment options, and prognosis. Learn about keratoacanthoma pathology, stages, and best practices for accurate medical coding and healthcare documentation for this rapidly growing skin tumor. This resource provides essential information for physicians, dermatologists, pathologists, and other healthcare professionals involved in the diagnosis and management of keratoacanthoma.
Also known as
Keratoacanthoma and other neoplasms
Includes keratoacanthoma and other specified epidermal neoplasms.
In situ neoplasms
Covers carcinoma in situ of various sites, sometimes a precursor to keratoacanthoma.
Skin cancer
Includes malignant neoplasms of the skin, which keratoacanthoma can mimic clinically.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the diagnosis keratoacanthoma?
Yes
Is it specified as giant keratoacanthoma?
No
Do not code keratoacanthoma. Review diagnosis.
When to use each related code
| Description |
|---|
| Rapidly growing, dome-shaped skin lesion. |
| Invasive, destructive skin cancer. |
| Slow-growing, pearly skin nodule. |
Using unspecified keratoacanthoma codes (e.g., L85.9) when a more specific location or type is documented, impacting reimbursement and data accuracy.
Misdiagnosis or coding confusion between keratoacanthoma and well-differentiated squamous cell carcinoma (e.g., C44.x), due to histologic similarities, leading to incorrect treatment and reporting.
Failing to document and code laterality (right/left) for keratoacanthoma of eyelid/eyelid skin, affecting data quality and potentially reimbursement for bilateral procedures.
Patient presents with a rapidly growing keratoacanthoma, clinically diagnosed as a cutaneous lesion. The lesion is dome-shaped, with a central keratin plug or crater and a characteristic appearance consistent with keratoacanthoma. Differential diagnosis includes squamous cell carcinoma, molluscum contagiosum, and verruca vulgaris. Location of the keratoacanthoma is documented as [insert location, e.g., right forearm, left cheek]. Size is measured as [insert size, e.g., 1.5 cm in diameter] with [insert description, e.g., well-defined borders]. Lesion color is [insert color, e.g., erythematous with a central yellowish core]. Patient denies any associated symptoms such as pain, pruritus, or bleeding. Patient history is reviewed, including sun exposure, prior skin cancer history, and relevant medical conditions. Biopsy is planned for histopathological confirmation of keratoacanthoma diagnosis and to rule out squamous cell carcinoma. Treatment options including surgical excision, curettage and electrodesiccation, cryotherapy, or intralesional chemotherapy will be discussed with the patient following biopsy results. ICD-10 code L82.0 will be utilized for medical billing and coding purposes. Patient education provided on keratoacanthoma prognosis, follow-up care, and sun protection.